Cargando…
SGLT2 Inhibitors and the Cardiorenal Continuum: A Paradigm Shift in the Treatment of Patients with T2D
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Healthcare
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9240134/ https://www.ncbi.nlm.nih.gov/pubmed/35704164 http://dx.doi.org/10.1007/s13300-022-01281-5 |
| _version_ | 1784737469992796160 |
|---|---|
| author | Escalada, Javier |
| author_facet | Escalada, Javier |
| author_sort | Escalada, Javier |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9240134 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Springer Healthcare |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-92401342022-06-30 SGLT2 Inhibitors and the Cardiorenal Continuum: A Paradigm Shift in the Treatment of Patients with T2D Escalada, Javier Diabetes Ther Editorial Springer Healthcare 2022-06-15 2022-07 /pmc/articles/PMC9240134/ /pubmed/35704164 http://dx.doi.org/10.1007/s13300-022-01281-5 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by-nc/4.0/Open AccessThis article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
| spellingShingle | Editorial Escalada, Javier SGLT2 Inhibitors and the Cardiorenal Continuum: A Paradigm Shift in the Treatment of Patients with T2D |
| title | SGLT2 Inhibitors and the Cardiorenal Continuum: A Paradigm Shift in the Treatment of Patients with T2D |
| title_full | SGLT2 Inhibitors and the Cardiorenal Continuum: A Paradigm Shift in the Treatment of Patients with T2D |
| title_fullStr | SGLT2 Inhibitors and the Cardiorenal Continuum: A Paradigm Shift in the Treatment of Patients with T2D |
| title_full_unstemmed | SGLT2 Inhibitors and the Cardiorenal Continuum: A Paradigm Shift in the Treatment of Patients with T2D |
| title_short | SGLT2 Inhibitors and the Cardiorenal Continuum: A Paradigm Shift in the Treatment of Patients with T2D |
| title_sort | sglt2 inhibitors and the cardiorenal continuum: a paradigm shift in the treatment of patients with t2d |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9240134/ https://www.ncbi.nlm.nih.gov/pubmed/35704164 http://dx.doi.org/10.1007/s13300-022-01281-5 |
| work_keys_str_mv | AT escaladajavier sglt2inhibitorsandthecardiorenalcontinuumaparadigmshiftinthetreatmentofpatientswitht2d |